Logo Image
How Oncology Nurses Can Overcome Common Barriers to Research

How Oncology Nurses Can Overcome Common Barriers to Research

Featuring By ONN Staff

Watch Now
Patient Safety First: How a CNS Bridges Oncology Research and the Bedside

Patient Safety First: How a CNS Bridges Oncology Research and the Bedside

Featuring By ONN Staff

Watch Now
Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

Watch Now
On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma

On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma

Featuring Alex Biese

Watch Now
Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

Watch Now
How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care

How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care

Featuring Alex Biese

Watch Now
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma

Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma

Featuring Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO, Sikander Ailawadhi, MD

Watch Now
Advocacy and Self-Care: Emily Beard on Oncology Navigation

Advocacy and Self-Care: Emily Beard on Oncology Navigation

Featuring Patricia Jakel, MN, RN, AOCN, Stephanie Desrosiers, DNP, MSN, RN, AOCNS, BMTCN, Emily Mason Beard, BSN, RN, OCN, CBCN

Watch Now

Trending Videos

October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
1

October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses

News

How Oncology Nurses Can Overcome Common Barriers to Research
2

How Oncology Nurses Can Overcome Common Barriers to Research

Commentary

Vicarious Trauma Affects Oncology Nurses in Every Care Setting
3

Vicarious Trauma Affects Oncology Nurses in Every Care Setting

Commentary

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
4

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer

Commentary

What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
5

What Nurses Should Tell Patients About Vitamin C in CCUS and MDS

Commentary

Creatine and Cancer Safety: Gabrielle Raucci Discusses Timing and Benefits
6

Creatine and Cancer Safety: Gabrielle Raucci Discusses Timing and Benefits

Commentary

Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
7

Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma

Commentary

Oncology Navigation: Closing Gaps in Survivorship With Emily Beard
8

Oncology Navigation: Closing Gaps in Survivorship With Emily Beard

Commentary

Patient Safety First: How a CNS Bridges Oncology Research and the Bedside
9

Patient Safety First: How a CNS Bridges Oncology Research and the Bedside

Commentary

How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care
10

How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care

Commentary

Shorts

Erika Hamilton, MD
1:31
Tucatinib Maintenance for HER2+ MBC: What Nurses Need to Know
18 days ago
by
Erika Hamilton, MD
Eppie Bass, APRN
1:29
Anktiva for Papillary NMIBC: A Moffitt NP’s Nursing Playbook
19 days ago
by
Eppie Bass, APRN
Beard and Brock
1:30
Survivors Are Asking About GLP-1s. Here’s How Nurses Answer
21 days ago
by
By ONN Staff
Faiman, Ailawadhi, Kuhns, Sorrentino
1:30
On-Body Injectors Arrive in Myeloma Care: What Nurses Need to Know
25 days ago
by
By ONN Staff
La-Urshalar Brock
1:31
MBC Awareness Day: What an NP and a Nurse-Patient Want Nurses to Know
a month ago
by
La-Urshalar Brock, MSN, FNP-BC, CNM
Ronnie Wilkie
0:45
Navigators Helped 73% of Relatives of BRCA Carriers Complete Testing
a month ago
by
Roni Nitecki Wilke, M.D., M.P.H.
FDA approval
1:31
FDA OKs Immunotherapy After Surgery for Stage 3 dMMR Colon Cancer
a month ago
by
By ONN Staff
FDA approval
1:16
FDA Approves Maintenance Tucatinib Regimen for HER2+ Breast Cancer
a month ago
by
By ONN Staff
FDA approval
1:17
FDA Approves Pirtobrutinib Tablets for First-Line Untreated CLL/SLL Care
a month ago
by
By ONN Staff
Suresh Rana, PhD
0:47
How AI Speeds Contouring and Planning in Radiation Oncology
a month ago
by
Suresh Rana, PhD

Expert Conversations

Expert Connections
Translating Trials
Case-Based Peer Perspectives

Shows & Podcast

Onc Nurse On Call

News & Analysis

Videos